Study of Tamibarotene in Patients With ADPKD
Phase 2
Active, not recruiting
- Conditions
- Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Rege Nephro Co., Ltd.
- Target Recruit Count
- 70
- Registration Number
- NCT06289998
- Locations
- π―π΅
Kurume University Hospital, Kurume, Fukuoka, Japan
π―π΅Hokkaido University Hospital, Sapporo, Hokkaido, Japan
π―π΅Shonan Kamakura General Hospital, Kamakura, Kanagawa, Japan
Β© Copyright 2025. All Rights Reserved by MedPath